Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 24 July 2008, doi:10.1136/bmj.a833
Cite this as: BMJ 2008;337:a833
Helen Rodgers, professor of stroke care 1,2, Mark Sudlow, honorary senior lecturer and consultant stroke physician1,2
1 School of Clinical Medical Sciences, Newcastle University, The Medical School, Newcastle upon Tyne NE2 4HH, 2 North Tyneside General Hospital, North Shields NE29 8NH
Correspondence to: H Rodgers helen.rodgers@newcastle.ac.uk
| The first 150 words of the full text of this article appear below. |
The guidelines from the National Institute for Health and Clinical Excellence (NICE) are a thorough and helpful summary of evidence in acute management of stroke and transient ischaemic attack.1 They are a welcome contribution to increasing understanding of stroke as a major cause of death and disability and to improving the structure and funding of services to tackle the problem.
Controversy is likely to centre on:
NICE guidance carries considerable influence over funding for services. It is therefore worrying that the Department of Health instructed NICE to examine only the first few days of treatment for a condition that often requires prolonged rehabilitation and long term support. Given fixed
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Read all Rapid Responses